Clinical and Translational Allergy,
Journal Year:
2023,
Volume and Issue:
13(10)
Published: Oct. 1, 2023
Abstract
Background
Allergic
diseases—rhinitis
and
asthma—are
the
most
common
chronic
conditions
affecting
adults.
Traditional
approaches
to
allergy
diagnosis
treatment
do
not
meet
health
needs
of
all
patients.
Treatment
adherence
remains
a
challenge
for
physicians.
The
ubiquity
Internet
access
paired
with
limited
in‐person
contact
medical
personnel
in
course
COVID‐19
pandemic
demonstrated
potential
mHealth
communicating
information.
Body
abundance
new
applications
dedicated
various
specialties
encourages
reflection
on
informed
use
such
tools.
paper
takes
closer
look
at
presents
conclusions
selected
studies
focusing
good
apps.
strength
weakness
opportunities
threats
analysis
was
used
illustrate
strengths
strategy,
as
well
its
advantages,
limitations
areas
need
further
development.
Conclusion
depends
quality
quantity
collected
patient
data,
reliable
processing,
publication
outcomes
from
analyses.
Therefore,
it
is
necessary
promote
validated
among
patients,
physicians
staff.
Allergy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 17, 2025
ABSTRACT
Background
Symptom
monitoring
can
improve
adherence
to
daily
medication.
However,
controlled
clinical
trials
on
multi‐modular
allergy
apps
and
their
various
functions
have
been
difficult
implement.
The
objective
of
this
study
was
assess
the
benefit
an
app
with
varying
numbers
in
reducing
symptoms
improving
quality
(QoL)
life
grass
pollen
allergic
individuals.
secondary
develop
a
symptom
forecast
based
patient‐derived
environmental
data.
Methods
We
performed
stratified,
intervention
(May–August
2023)
participants
(
N
=
167)
Augsburg,
Germany.
Participants
were
divided
into
three
groups,
each
receiving
same
app,
but
increasing
functions.
Primary
endpoint:
rhinitis‐related
QoL;
Secondary
endpoints:
scores,
relevant
behavior,
self‐reported
usefulness
forecast.
Results
Rhinitis‐related
QoL
increased
after
intervention,
no
statistical
inter‐group
differences.
access
full
version,
including
forecast,
took
more
medication
reported
lower
social
activity
impairment
than
reduced‐function
app.
Using
XGBoost
multiclass
classification
model,
we
achieved
promising
results
for
predicting
nasal
(accuracy:
0.79;
F1‐score:
0.78)
ocular
0.82;
0.76)
levels
derived
feature
importance
using
SHAP
as
guidance
future
approaches.
Conclusion
Our
its
high‐performance
diary,
general
allergy‐related
information
provides
sufferers.
Reliable
forecasts
may
be
created
given
high‐quality
high‐resolution
Journal of Asthma and Allergy,
Journal Year:
2023,
Volume and Issue:
Volume 16, P. 1087 - 1095
Published: Oct. 1, 2023
Abstract:
Allergic
rhinitis
(AR)
is
a
common
disease,
characterized
by
typical
symptoms
and
type
2
inflammation.
Standard
treatment
usually
effective
safe,
most
medications
are
available
as
over-the-counter
(OTC).
Therefore,
AR
patients,
mostly
at
the
onset
or
if
mild,
prefer
to
manage
themselves.
However,
self-management
could
be
associated
with
problems,
including
inadequate
control
medication
abuse.
this
paper
aimed
presenting
discussing
issue.
Ideally,
should
conducted
under
medical
supervision.
In
regard,
telemedicine
represent
valuable
tool
for
implementing
self-management.
Visual
analog
scale
(VAS)
perfect
parameter
measure
symptom
severity,
use,
control.
addition,
VAS
easily
monitored
over
time.
Presently,
mobile
application
allows
patients
of
self-managing
healthcare
may
supply
fundamental
support
in
communication
decision-making.
represents
best
monitor
symptoms'
severity
Finally,
pharmacological
non-pharmacological
remedies
numerous
but
used
wisely.
Keywords:
allergic
rhinitis,
self-management,
healthcare,
visual
scale,
World Allergy Organization Journal,
Journal Year:
2024,
Volume and Issue:
17(3), P. 100873 - 100873
Published: March 1, 2024
Allergic
rhinitis
(AR)
is
a
chronic
respiratory
condition
that
internationally
continues
to
be
burdensome
and
impacts
quality
of
life.
Despite
availability
medicines
guidelines
for
healthcare
providers
the
optimal
management
AR,
optimisation
its
in
community
elusive.
The
reasons
this
are
multi-faceted
include
both
environmental
related
factors.
One
factor
we
can
no
longer
ignore
AR
limited
domain
provider
people
with
make
their
own
choices
when
choosing
how
manage
condition,
without
seeking
advice
from
health
care
provider.
We
must
build
bridge
between
knowledge
patient
decision-making.
With
commentary,
propose
shared
decision-making
approach
professionals
developed
promoted,
focus
on
literacy.
As
custodians
knowledge,
have
responsibility
ensure
it
accessible
those
matter
most—the
AR.
Journal of Investigational Allergology and Clinical Immunology,
Journal Year:
2024,
Volume and Issue:
34(3), P. 148 - 156
Published: May 14, 2024
In
chronic
diseases,
mHealth
apps
help
to
improve
clinical
management
and
provide
valuable
real-world
scientific
evidence.
allergic
rhinitis,
a
market
research
study
identified
only
4
that
were
multilingual,
resulted
in
publications,
displayed
comprehensive
list
of
medications.
Of
these
apps,
MASK-air®
generated
the
highest
number
publications.
MASK-air
was
launched
2015
is
currently
available
30
countries,
with
data
collected
from
more
than
000
users.
It
comprises
daily
monitoring
questionnaire,
enabling
patients
register
their
allergy
symptoms
by
means
visual
analog
scales
medication
use.
The
achievements
include
development
2
digital
biomarkers
for
rhinitis
asthma
(combined
symptom-medication
score
electronic
control
score).
have
also
made
it
possible
assess
patients’
behavior,
suggesting
do
not
follow
guideline
recommendations,
but
rather
treat
themselves
(and
often
use
comedication)
when
they
feel
worse.
Using
data,
we
quantified
impact
diseases
on
quality
life
school
work
productivity.
Realworld
are
being
used
as
source
evidence
Allergic
Rhinitis
its
Impact
Asthma
2024
guidelines
an
innovative
process
incorporation
mobile
health
into
guidelines.
This
review
discusses
contributions
person-centred
care
asthma,
providing
illustrative
example
diseases.
Clinical and Experimental Pediatrics,
Journal Year:
2024,
Volume and Issue:
67(6), P. 267 - 273
Published: May 21, 2024
Action-plan
is
a
written
set
of
instructions
that
helps
patient
manage
their
symptoms
and
respond
to
worsening
condition.
The
action-plan
usually
includes
information
on
how
recognize,
treat,
prevent
symptoms.
plan
also
understand
when
use
medications,
much
use,
often
them
as-needed.
An
should
be
developed
through
discussion
between
the
physician,
reflecting
patient's
severity,
preferences,
values
regularly
updated
reflect
changes
in
person's
In
asthma,
action-plans
as-needed
therapy
are
already
well
utilized.
Unlike
importance
an
has
been
overlooked
allergic
rhinitis
(AR),
but
its
recently
recognized.
AR
chronic
condition
affects
people
differently,
can
cause
range
symptoms,
including
nasal
congestion,
runny
nose,
sneezing,
itching,
watery
eyes.
Therefore,
help
patients
these
more
effectively,
reducing
impact
daily
activities
quality
life.
Furthermore,
it
tailored
meet
personal
needs
each
patient,
based
severity
triggers,
overall
health.
Because
adhere
treatment
regimen
by
providing
clear
take
medication,
stay
track
with
treatment,
likelihood
missed
doses
failures.
Overall,
important
components
comprehensive
for
AR.
They
improve
symptom
control,
complications,
promote
adherence
leading
better
outcomes
higher
